Ono Pharmaceutical Company Ltd (PK) (OPHLY) 뉴스

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

  333-153926   SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

      As filed with the Securities and Exchange Commission on May 22, 2017 Regi...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF...

Amended Securities Registration (ads, Delayed) (f-6/a)

As filed with the Securities and Exchange Commission on April 25, 2017 Registration No. 333-214131   ...

Securities Registration (ads, Delayed) (f-6)

As filed with the Securities and Exchange Commission on October 17, 2016 Registration No. 333-    ...

Securities Registration (ads, Immediate) (f-6ef)

  SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM...

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

As filed with the Securities and Exchange Commission on May 24, 2016 Registration No. 333-154897   SECURITIE...

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

Securities Registration (ads, Immediate) (f-6ef)

  As filed with the...

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

  As filed with the Securities and Exchange Commission on May 23, 2014 Registration No...

OTC Markets Group Announces First Quarter 2014 Performance of OTCM ADR Index

OTC Markets Group Announces First Quarter 2014 Performance of OTCM ADR Index PR Newswire NEW YORK, April 28, 2014 NEW YORK, April 28, 2014...

AMRI and Ono Broaden SMARTSOURCING™ Collaboration

AMRI and Ono Broaden SMARTSOURCING™ Collaboration PR Newswire ALBANY, New York, April 23, 2013 - New Agreement Extends Drug Discovery and...